阿扎胞苷用于80岁以上急性髓系白血病或骨髓增生异常综合征患者：115例患者的报告 - Suppr

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.

作者信息

Peterlin Pierre, Cluzeau Thomas, Jullien Maxime, Ngo Nloga Anne-Marie, Calleja Anne, Angeli Eurydice, Chevallier Patrice, Guillaume Thierry, Garnier Alice, Le Bourgeois Amandine, Le Gouill Steven, Fenaux Pierre, Adès Lionel, Bally Cécile

机构信息

Service d'hématologie Clinique, CHU de Nantes, France.

Service d'hématologie Clinique, CHU de Nice, France.

出版信息

Br J Haematol. 2020 Aug;190(3):461-464. doi: 10.1111/bjh.16680. Epub 2020 May 11.

DOI:10.1111/bjh.16680

PMID:32394477

Abstract

摘要

相似文献

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.阿扎胞苷用于80岁以上急性髓系白血病或骨髓增生异常综合征患者：115例患者的报告

Br J Haematol. 2020 Aug;190(3):461-464. doi: 10.1111/bjh.16680. Epub 2020 May 11.

Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey.阿扎胞苷对比利时高危骨髓增生异常综合征、急性髓系白血病或慢性粒单核细胞白血病患者的安全性和有效性：一项真实、非干预性上市后调查的结果

Acta Clin Belg. 2015 Feb;70(1):34-43. doi: 10.1179/2295333714Y.0000000102. Epub 2014 Dec 2.

Safety and efficacy of azacitidine in myelodysplastic syndromes.阿扎胞苷在骨髓增生异常综合征中的安全性和有效性。

Drug Des Devel Ther. 2010 Sep 24;4:221-9. doi: 10.2147/dddt.s3143.

Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia.不同阿扎胞苷剂量方案治疗骨髓增生异常综合征或急性髓系白血病患者的疗效和安全性。

Leuk Res. 2014 Jul;38(7):744-50. doi: 10.1016/j.leukres.2014.03.004. Epub 2014 Mar 19.

Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study.高危骨髓增生异常综合征和急性髓系白血病患者序贯使用阿扎胞苷和来那度胺：一项单臂1/2期研究。

Lancet Haematol. 2015 Jan;2(1):e12-20. doi: 10.1016/S2352-3026(14)00026-X. Epub 2014 Dec 22.

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.急性髓系白血病或骨髓增生异常综合征移植后复发患者接受阿扎胞苷治疗期间系列骨髓样本的突变分析。

Haematologica. 2017 Jun;102(6):e216-e218. doi: 10.3324/haematol.2016.162909. Epub 2017 Feb 16.

[5-day decitabine for treatment of myelodysplastic syndromes with complex karyotype abnormalities and acute myeloid leukemia].5天阿扎胞苷治疗伴有复杂核型异常的骨髓增生异常综合征及急性髓系白血病

Zhonghua Xue Ye Xue Za Zhi. 2013 Jun;34(6):542-3. doi: 10.3760/cma.j.issn.0253-2727.2013.06.019.

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM).阿扎胞苷治疗费城染色体阴性骨髓增殖性肿瘤向骨髓增生异常综合征或急性髓系白血病的进展：代表法国骨髓增生异常综合征研究组（GFM）的 54 例报告。

Blood. 2010 Nov 11;116(19):3735-42. doi: 10.1182/blood-2010-03-274811. Epub 2010 Jul 27.

Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study.阿扎胞苷治疗的骨髓增生异常综合征、急性髓系白血病和慢性粒单核细胞白血病患者感染风险的预测模型；阿扎胞苷感染风险模型：波兰成人白血病组研究

Clin Lymphoma Myeloma Leuk. 2019 May;19(5):264-274.e4. doi: 10.1016/j.clml.2019.01.002. Epub 2019 Jan 23.

Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.阿扎胞苷：在骨髓增生异常综合征和急性髓系白血病中的综述。

Drugs. 2016 May;76(8):889-900. doi: 10.1007/s40265-016-0585-0.

引用本文的文献

Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee.基于低甲基化剂的治疗在老年急性髓系白血病中的应用 - 老年肿瘤学的青年国际学会和欧洲血液和骨髓移植协会学员委员会的联合综述。

J Geriatr Oncol. 2023 Apr;14(3):101406. doi: 10.1016/j.jgo.2022.11.005. Epub 2022 Nov 23.

Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition.三阴性乳腺癌中蛋白质编码和非编码RNA在DNA甲基转移酶抑制作用下的转录改变

Cancer Cell Int. 2021 Sep 26;21(1):515. doi: 10.1186/s12935-021-02213-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献